Aspiriant LLC’s iShares Morningstar US Equity ETF ILCB Stock Holding History

Aspiriant LLC’s Portfolio ILCB Stock Details ILCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-12,180	Closed	-$376K	–	94
2014 Q4	$376K	Sell	12,180 -17,176	-59%	-$515K	0.05%	66
2014 Q3	$845K	Sell	29,356 -26,284	-47%	-$756K	0.12%	40
2014 Q2	$1.58M	Sell	55,640 -15,684	-22%	-$438K	0.22%	28
2014 Q1	$1.97M	Buy	+71,324	New	+$1.91M	0.29%	27

Other funds holding ILCB

CAG

Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Aspiriant LLC's ILCB Position: Q1 2015 in Review

Aspiriant LLC sold out of iShares Morningstar US Equity ETF (ILCB) in Q1 2015, closing a stake of 12,180 shares — an estimated $376K sold.

Aspiriant LLC first reported a position in ILCB in Q1 2014 and held it in 4 quarters. The position peaked at $1.97M in Q1 2014. 63 funds tracked by Wall St. Rank hold ILCB as of Q1 2015.

Aspiriant LLC reported no remaining iShares Morningstar US Equity ETF position as of Q1 2015 after selling out during the quarter.
Aspiriant LLC sold 12,180 iShares Morningstar US Equity ETF shares in Q1 2015, an estimated $376K.
Aspiriant LLC first reported a position in iShares Morningstar US Equity ETF in Q1 2014 and held it in 4 quarters.
Aspiriant LLC's iShares Morningstar US Equity ETF position peaked at $1.97M in Q1 2014.
63 funds tracked by Wall St. Rank held iShares Morningstar US Equity ETF as of Q1 2015.

Based on Aspiriant LLC's 13F filing for Q1 2015, filed 8 May 2015.